Life Settlements: An Uncorrelated, High-Yield Asset Class on the Rise
- Yaniv Bertele
- Sep 23, 2025
- 7 min read
Introduction
In today’s volatile financial landscape, institutional investors are seeking havens of stability and diversification. The past few years – marked by pandemic disruptions, inflationary pressures, and synchronized stock-bond drawdowns – have underscored the importance of assets that can withstand market swings. Alternative investments have expanded from private equity and real estate into more esoteric areas, and one niche asset class is increasingly catching the eye of pension funds, family offices, and asset managers: life settlements. A life settlement involves the purchase of an existing life insurance policy from its original owner, allowing the investor to pay the premiums and eventually collect the death benefit. This strategy unlocks value from an otherwise illiquid asset, creating a stream of returns decoupled from traditional market drivers. In a world desperate for uncorrelated yield, life settlements are emerging as a timely solution.

Investment Case
Why should institutional investors consider life settlements? In short: diversification, yield, and security. Life settlement returns have low correlation to stocks and bonds, providing true diversification in a portfolio. Unlike equities (tied to corporate earnings or economic cycles) or bonds (sensitive to interest rates), the performance of life settlements hinges on a completely different variable – human longevity. This means portfolio risk can be reduced by adding an asset whose outcomes do not move in tandem with market crises. In fact, over 80% of investors in a recent study cited diversification as a key advantage of life settlements [1]. Moreover, these policies can generate high returns relative to many traditional assets. Industry data show net expected IRRs in the high-single to low-double digits (approximately 8%–11% on a net basis) for diversified life settlement portfolios [2]. Such yields outpace typical fixed-income instruments – especially valuable in an environment where core bond yields have been low or volatile.
Life settlements have even been positioned as an alternative to high-yield bonds, delivering better risk-adjusted returns by offsetting equity risk without the credit downgrades seen in corporate debt. Finally, the underlying collateral of a life settlement – the insurance policy’s payout – is backed by investment-grade life insurance carriers. These are highly regulated institutions with strong credit ratings, providing an extra layer of security and making the asset’s payoff akin to an investment-grade obligation. In essence, life settlements present a compelling case as a high-yield, low-beta addition to institutional portfolios, combining the upside of alternative investments with the downside protection of insurance-backed assets.
Risk and Return Profile
During major financial crises, life settlements have demonstrated remarkable resilience, maintaining steady, uncorrelated returns while traditional asset classes experienced sharp drawdowns.

The graph above illustrates a comparative analysis of S&P 500 equities, U.S. bonds and life settlements from 2018 to 2024, covering the 2022 Bear Markets crisis and the 2020 COVID-19 crash
From an investment perspective, this stability translates into high risk-adjusted returns, making life settlements a valuable addition to institutional portfolios. The asset class’ ability to generate consistent, non-market-dependent cash flows ensures predictability and resilience, especially in turbulent economic environments.
This low-beta behavior highlights how life settlements can buffer a portfolio during market stress, offering true diversification when it’s needed most. On the return side, life settlements deliver attractive yields. Portfolios of seasoned life policies are often priced at discount rates in the low-to-mid teens (e.g. 13–16% IRR), translating into realized net returns around 8–12% over time. These returns accrue with relatively low volatility; cash flows (death benefit payouts) are irregular in timing but statistically predictable across a large pool of policies. Key risks are inherent – chiefly longevity risk (the insured living longer than expected) and liquidity risk (capital is tied up until policy maturities). However, robust risk mitigation is possible. By holding a diversified portfolio of hundreds of policies, investors can average out individual lifespan variations, achieving more stable outcomes through the law of large numbers.
Many funds actively manage premium payments and maintain reserves to ensure policies stay in force even if life expectancies extend. Meanwhile, credit risk is limited by focusing on policies issued by highly rated insurers, and regulatory oversight in the life settlement industry helps protect against fraud and mispricing. The end result is a unique asset class offering stable, uncorrelated cash flows with competitive returns – a rare combination in the investment universe.
Technology’s Role in Improving Performance
Advances in technology – particularly in data analytics and AI – are revolutionizing life settlement investing. One of the biggest challenges (and opportunities) in this asset class is accurately estimating longevity. Traditionally, life expectancy underwriting relied on actuarial tables and expert medical review, which, while rigorous, had its limitations. Today, AI-driven models analyze vast datasets (medical records, demographic trends, lifestyle data) to predict life expectancies with ever-improving accuracy [3]. Machine learning algorithms can continuously incorporate new information – from changes in an individual’s health to broader medical advancements – and adjust mortality projections in real time. This means pricing of policies is becoming more precise, reducing the risk of under- or over-paying for a policy. Tech-driven underwriting also speeds up the investment process: algorithms can rapidly sift through electronic health records and insurance data to identify attractive policies, performing in seconds what used to take weeks of human analysis. In parallel, technology is enhancing risk management. AI-based tools are now used to detect anomalies in documents and medical history, flagging potential fraud or errors before an investment is made. Portfolio management systems can optimize premium financing and monitor interest rate and credit conditions to dynamically adjust holding strategies. All these innovations contribute to a more efficient market. Better longevity estimates lead to more reliable returns – as pricing aligns closer with reality, actual performance of life settlement portfolios has less variance from expected performance. Investors benefit through higher confidence and potentially higher returns, as fewer surprises (like unexpectedly long-lived cohorts or overlooked health data) derail the projections. In short, technology is taking a once opaque, relationship-driven market and bringing it into the realm of transparent, data-driven investing, thereby improving outcomes for all participants.
Future Outlook: Growth and Opportunity
The life settlements sector is at an inflection point of growth, driven by converging tailwinds in demographics, investor demand, and regulatory maturity. On the supply side, an aging population means more policies potentially available for sale. Every year, seniors over age 65 lapse or surrender over $100 billion of life insurance face value that they no longer need or can afford [4]. This represents a vast reservoir of assets that could instead be monetized through life settlements – a win-win for seniors (who receive cash payouts far above surrender values) and investors (who gain access to these policy benefits). As awareness increases – aided by financial advisors and even state legislatures mandating consumer disclosure of the life settlement option – policy flow into the secondary market is expected to rise, expanding the investment universe. On the demand side, institutional interest is surging.
A 2024 global survey of institutional investors found nearly 65% are moderately or extremely likely to invest in life settlements in the next 1–2 years [5]. More than two-thirds believe pensions and endowments will keep increasing allocations over the next five years. In the very near term, 44% of active investors plan to boost their allocations in the coming year alone. This growing appetite is fueled by the factors discussed: low correlation (one-third of investors polled cite non-correlation as a key attraction) and consistently attractive returns (around 40% believe life settlement funds can deliver steady high returns). Importantly, regulatory developments have turned favorable, adding confidence to the market. In the U.S., 43 of 50 states now have specific regulations governing life settlements, providing a robust framework that protects policy sellers and investors alike. Over half of surveyed investors (55%) say recent regulatory changes have made the asset class much safer.
Industry groups in North America and Europe (e.g., LISA and ELSA) have improved transparency and best practices, shedding the checkered reputation the market might have had in its early days. Going forward, we can expect continued institutionalization of this niche – more large players entering, greater standardization, and potentially even enhanced liquidity via trading platforms or securitizations. Additionally, flexible fund structures and domiciles are making it easier for global investors to participate.
Life settlement funds can be domiciled in investor-friendly jurisdictions (from Cayman to Luxembourg) and structured to fit regulatory and tax considerations, which lowers barriers for pensions or international allocators to get on board. All these trends point to a robust growth trajectory for life settlements. What was once a obscure corner of alternative investments is fast becoming a mainstream diversifier, with the potential market size expanding and acceptance rising.
Conclusion
Life settlements have arrived as a compelling asset class for institutional portfolios, offering a rare mix of high yields, low correlation, and intrinsic downside protection. At a macro level, they address many challenges facing investors today: the need for true diversification in the face of market volatility, the pursuit of enhanced returns in a low-yield world, and the desire for assets with tangible, investment-grade backing.
Thanks to technological advancements and a maturing market infrastructure, many of the historical uncertainties in life settlements are being reined in – making the space more transparent and efficient than ever before.
Meanwhile, strong demographic and regulatory tailwinds are expanding the opportunity set and lowering risk.
The message for pension funds, endowments, family offices, and other capital market professionals is clear: now is the time to engage with life settlements. By taking a strategic, informed approach – partnering with experienced managers who leverage cutting-edge underwriting and prudent structuring – institutions can tap into this burgeoning sector to bolster portfolio resilience and performance.
In an era defined by uncertainty, life settlements provide a timely avenue for stable, uncorrelated growth.


Comments